03.05.2015 Views

Here - EWMA 2013

Here - EWMA 2013

Here - EWMA 2013

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

POSTER: DRESSINGS<br />

Poster: Dressings<br />

P 288<br />

Clinical experience with a novel absorbent antimicrobial<br />

wound dressing – a multi-centre study<br />

Friedhelm Lang 1 , Anja Süß-Burghart 2 , Andreas Matthies 3<br />

1 Surgical Department, Leonberg District Hospital (Leonberg, Germany);<br />

2 Klinikum Schwabing (Munich, Germany);<br />

3 BSN medical (Hamburg, Germany).<br />

In the treatment of non-healing wounds, the choice of a suitable wound dressing is an<br />

important factor to support wound improvement. These wounds are often characterized<br />

by bacterial infection, increased inflammation, varying exudate levels and the presence<br />

of necrotic and sloughy tissue. In the present study, the efficacy and performance of a<br />

novel bacteria-binding and absorbent wound dressing* was assessed. The new wound<br />

dressing is indicated for contaminated, colonised or infected wounds with medium to<br />

high exudate levels. A multi-centre study in Germany on 144 patients was conducted<br />

and healthcare professionals rated the performance of the bacteria-binding, absorbent<br />

wound dressing* in the treatment of different wounds. For an average of 12 days, all<br />

wounds were treated with the dressing and the following parameters were measured: (1)<br />

handling, (2) infection signs/infection control, (3) exudate and (4) odour levels as well as<br />

improvement of wound healing (5).<br />

In the time of treatment, the bacteria-binding wound dressing* reduced the signs of<br />

infection in wounds from 59% to 35%. Most of the evaluated wounds showed reduced<br />

exudate and odour levels and wound healing markedly improved. Moreover, since the<br />

dressing does not release any active component many clinicians chose to use the<br />

dressing for infection prevention.<br />

In conclusion, this multi-centre study demonstrates that novel bacteria-binding and<br />

absorbent wound dressing* combines effective topical infection control and management<br />

with exudate management.<br />

*Cutimed ® Siltec Sorbact ® , BSN medical<br />

P 289<br />

Poster: Dressings<br />

IMPACT OF FOAM DRESSINGS WITH SMALL PORES AND NARROW PORE<br />

DISTRIBUTION ON THE UPTAKE OF HIGHLY VISCOUS EXUDATE<br />

Sascha Casu 1 , Marco Schubert 1<br />

1 BSN medical GmbH (Hamburg, Germany).<br />

Introduction and Aim: Foam products are known for good fluid handling capacities<br />

often measured with SolA (salt solution). Application of SolA cannot predict how foam<br />

products will behave in real conditions since the absence of proteins which tend to<br />

increase viscosity over time and leading to encrustations in and around the foams.<br />

This test aims on showing the impact of foam structure on the ability to handle highly<br />

viscous fluid shown in artificial wound model.<br />

Methods: Foam dressings were put on a plate (37°C), through a hole in the middle an<br />

albumin/pectin test solution was fed into the products (size 10x10 cm, 5 mm foam) at<br />

2ml/hr over approx. 16 hours. A box (MVTR) on top filled with silica gel catches the<br />

evaporated amount of water. Determination of gravimetric difference of the dressings<br />

and the MVTR box before and after measurement and substraction from the initial<br />

amount gets the absorption, MVTR and residue in the system. After measurement<br />

photos of foam were taken to examine the uptake of fluid in the foam.<br />

Results: It was found that foams with small pores separate the solid content from the<br />

water which leads to encrustations on the model’s wound surface. Exemplary<br />

comparison of 4 foam dressings*.<br />

Conclusion: Fluids with high solid content like exudate with cell debris, proteins and<br />

blood hardeners get filtered by small pored dressings so that heavy parts would reside<br />

on the patient’s wound surface.<br />

*Biatain, Cutimed Siltec and Allevyn.<br />

<strong>EWMA</strong> <strong>2013</strong><br />

COPENHAGEN<br />

15-17 May · <strong>2013</strong><br />

Danish Wound<br />

Healing Society<br />

173

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!